Article 1
The Annex to Regulation (EU) No 37/2010 is amended as set out in the Annex to this Regulation.
Commission Implementing Regulation (EU) 2016/576 of 14 April 2016 amending Regulation (EU) No 37/2010 as regards the substance ‘rafoxanide’ (Text with EEA relevance)
Data as of 2026-07-04 · Compiled from an official source version. Later amendments or repeals may not be reflected; the official text prevails. · Read the official text ↗
The Annex to Regulation (EU) No 37/2010 is amended as set out in the Annex to this Regulation.
This Regulation shall enter into force on the day of its publication in the Official Journal of the European Union . It shall apply from 1 January 2016.
ANNEX In Table 1 of the Annex to Regulation (EU) No 37/2010, the entry for the substance ‘rafoxanide’ is replaced by the following: Pharmacologically active Substance Marker residue Animal Species MRL Target Tissues Other Provisions (according to Article 14(7) of Regulation (EC) No 470/2009) Therapeutic Classification ‘Rafoxanide Rafoxanide Bovine 30 μg/kg 30 μg/kg 10 μg/kg 40 μg/kg Muscle Fat Liver Kidney NO ENTRY Antiparasitic agents/Agents against endoparasites’ Ovine 100 μg/kg 250 μg/kg 150 μg/kg 150 μg/kg Muscle Fat Liver Kidney Bovine, ovine 10 μg/kg Milk Provisional MRL shall expire on 31 December 2017
Source: EUR-Lex (Publications Office of the EU), © European Union, reuse permitted under Commission Decision 2011/833/EU.